284 related articles for article (PubMed ID: 6181282)
21. Effect of streptococcal lyzate OK-432 on peripheral blood mononuclear cells in gastric cancer patients.
Nakayama F; Iwagaki H; Gouchi A; Hizuta A; Isozaki H; Takakura N; Tanaka N
J Med; 1998; 29(3-4):199-215. PubMed ID: 9865458
[TBL] [Abstract][Full Text] [Related]
22. Regulation of human natural killer cell activity by interferon-gamma: lack of a role in interleukin 2-mediated augmentation.
Sayers TJ; Mason AT; Ortaldo JR
J Immunol; 1986 Mar; 136(6):2176-80. PubMed ID: 3081640
[TBL] [Abstract][Full Text] [Related]
23. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
[TBL] [Abstract][Full Text] [Related]
24. In vitro augmentation of natural killing activity by OK-432.
Uchida A; Micksche M
Int J Immunopharmacol; 1981; 3(4):365-75. PubMed ID: 6174467
[TBL] [Abstract][Full Text] [Related]
25. In vitro augmentation of human natural killer (NK) cell activity by a streptococcal preparation OK-432 and its extracts, protein M and polysaccharides.
Wakasugi H; Oshimi K; Kasahara T; Miyata M; Morioka Y
Int Arch Allergy Appl Immunol; 1982; 67(4):322-8. PubMed ID: 7040254
[TBL] [Abstract][Full Text] [Related]
26. Role of interleukin-2 and interferon-gamma in induction of activated natural killer cells from mice primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432.
Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K; Kuribayashi K; Saito K
Cancer Immunol Immunother; 1989; 29(2):79-86. PubMed ID: 2497980
[TBL] [Abstract][Full Text] [Related]
27. Induction of natural killer-like cytotoxicity in cultured human thymocytes.
Toribio ML; De Landázuri MO; López-Botet M
Eur J Immunol; 1983 Dec; 13(12):964-9. PubMed ID: 6581975
[TBL] [Abstract][Full Text] [Related]
28. OK-432 stimulates primary production and activity of murine natural killer cells.
Pollack SB
Nat Immun Cell Growth Regul; 1987; 6(5):224-36. PubMed ID: 3444437
[TBL] [Abstract][Full Text] [Related]
29. Studies of the enhancement of natural cytotoxicity by the streptococcal immunopotentiator OK432.
Christmas SE; Meager A; Moore M
Int J Immunopharmacol; 1986; 8(1):83-92. PubMed ID: 2420735
[TBL] [Abstract][Full Text] [Related]
30. [Oral administration of OK-432 (picibanil). (8th report) clinical application: its immunomodulatory effects on the patients with gastrointestinal cancers].
Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1607-15. PubMed ID: 2809385
[TBL] [Abstract][Full Text] [Related]
31. OK-432 and IL-2-augmented cytotoxicity of human natural killer cells and cytotoxic T lymphocytes at the clonal level.
Gravekamp C; Vreugdenhil R; Bolhuis RL
FEMS Microbiol Immunol; 1988 Jan; 1(1):31-9. PubMed ID: 2978812
[TBL] [Abstract][Full Text] [Related]
32. Effects of intradermal administration of streptococcal preparation OK-432 on interferon and natural killer cell activities in patients with oral cancer.
Sato M; Yoshida H; Yanagawa T; Yura Y; Urata M; Atsumi M; Hayashi Y; Takegawa Y
Int J Oral Surg; 1984 Feb; 13(1):7-15. PubMed ID: 6203858
[TBL] [Abstract][Full Text] [Related]
33. Production of tumor necrosis factor (TNF) by monocytes from cancer patients and healthy subjects induced by OK-432 in vitro, and its augmentation by human interferon gamma.
Sekimoto M; Kokunai I; Shimano T; Kobayashi T; Takeda T; Haruna N; Yamamoto A; Mori T
J Clin Lab Immunol; 1988 Nov; 27(3):115-20. PubMed ID: 3150012
[TBL] [Abstract][Full Text] [Related]
34. [Observation on natural killer cell activity in gastric cancer patients and effect of nonspecific immunopotentiator administration on its postoperative reduction].
Oshita H; Saji S; Sugiyama Y; Tanemura H; Sakata K; Tanaka S; Ito T
Nihon Geka Gakkai Zasshi; 1985 Oct; 86(10):1417-25. PubMed ID: 4079897
[TBL] [Abstract][Full Text] [Related]
35. Characterization of mouse natural killer cell activating factor (NKAF) induced by OK-432: evidence for interferon- and interleukin 2-independent NK cell activation.
Ichimura O; Suzuki S; Sugawara Y; Osawa T
Br J Cancer; 1984 Jul; 50(1):97-108. PubMed ID: 6204667
[TBL] [Abstract][Full Text] [Related]
36. Effect of biological response modifier-streptococcal preparation OK-432 on NK/K cell system of gnotobiotic miniature swine.
Kim YB
Prog Clin Biol Res; 1985; 181():337-41. PubMed ID: 4063011
[No Abstract] [Full Text] [Related]
37. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
Muralikrishna K; Varalakshmi C; Khar A
Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
[TBL] [Abstract][Full Text] [Related]
38. hsBAFF enhances activity of NK cells by regulation of CD4(+) T lymphocyte function.
Zhang W; Wen L; Huang X; Liang J; Gao W; Zhang S; Chen L
Immunol Lett; 2008 Oct; 120(1-2):96-102. PubMed ID: 18687360
[TBL] [Abstract][Full Text] [Related]
39. Augmentation of natural killer (NK) cell activity by a streptococcal preparation, OK-432, in patients with malignant tumors.
Wakasugi H; Oshimi K; Miyata M; Morioka Y
J Clin Immunol; 1981 Jul; 1(3):154-62. PubMed ID: 6174541
[TBL] [Abstract][Full Text] [Related]
40. Blastogenic responses of human lymphocytes to a streptococcal preparation OK-432 and its fractions.
Tanaka T; Kaneko Y; Haba F; Katsuta S; Tsutsui K; Tamaki S; Chen DR; Suzuki S; Ueda R; Yamamoto A
J Clin Lab Immunol; 1989 Feb; 28(2):91-6. PubMed ID: 2787407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
